257 related articles for article (PubMed ID: 11887802)
1. Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate/lactate-based peritoneal dialysis solutions.
Cooker LA; Luneburg P; Holmes CJ; Jones S; Topley N;
Perit Dial Int; 2001; 21 Suppl 3():S102-7. PubMed ID: 11887802
[TBL] [Abstract][Full Text] [Related]
2. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
[TBL] [Abstract][Full Text] [Related]
3. Generation of TNFalpha and interleukin-6 by peritoneal macrophages after overnight dwells with bicarbonate- or lactate-buffered dialysis fluid.
Liberek T; Lichodziejewska-Niemierko M; Knopinska-Posluszny W; Schaub TP; Kirchgessner J; Passlick-Deetjen J; Rutkowski B
Perit Dial Int; 2002; 22(6):663-9. PubMed ID: 12556067
[TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal IL-6 signaling in incident patients treated with icodextrin and glucose bicarbonate/lactate-based peritoneal dialysis solutions.
Opatrna S; Lysak D; Trefil L; Parker C; Topley N
Perit Dial Int; 2012; 32(1):37-44. PubMed ID: 22302924
[TBL] [Abstract][Full Text] [Related]
5. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study.
Fusshoeller A; Plail M; Grabensee B; Plum J
Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322
[TBL] [Abstract][Full Text] [Related]
6. Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function.
Jones S; Holmes CJ; Mackenzie RK; Stead R; Coles GA; Williams JD; Faict D; Topley N
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S97-103. PubMed ID: 11792769
[TBL] [Abstract][Full Text] [Related]
7. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
[TBL] [Abstract][Full Text] [Related]
8. Differences in peritoneal response after exposure to low-GDP bicarbonate/lactate-buffered dialysis solution compared to conventional dialysis solution in a uremic mouse model.
Vila Cuenca M; Keuning ED; Talhout W; Paauw NJ; van Ittersum FJ; Ter Wee PM; Beelen RHJ; Vervloet MG; Ferrantelli E
Int Urol Nephrol; 2018 Jun; 50(6):1151-1161. PubMed ID: 29728994
[TBL] [Abstract][Full Text] [Related]
9. Short-term effects of a new bicarbonate/lactate-buffered and conventional peritoneal dialysis fluid on peritoneal and systemic inflammation in CAPD patients: a randomized controlled study.
Pajek J; Kveder R; Bren A; Gucek A; Ihan A; Osredkar J; Lindholm B
Perit Dial Int; 2008; 28(1):44-52. PubMed ID: 18178947
[TBL] [Abstract][Full Text] [Related]
10. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.
Plum J; Schoenicke G; Grabensee B
Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571
[TBL] [Abstract][Full Text] [Related]
11. Cell-free DNA in the peritoneal effluent of peritoneal dialysis solutions.
Pajek J; Kveder R; Gucek A; Skoberne A; Bren A; Bucar M; Cerne D; Lukac-Bajalo J
Ther Apher Dial; 2010 Feb; 14(1):20-6. PubMed ID: 20438516
[TBL] [Abstract][Full Text] [Related]
12. The association between the vascular endothelial growth factor-to-cancer antigen 125 ratio in peritoneal dialysis effluent and the epithelial-to-mesenchymal transition in continuous ambulatory peritoneal dialysis.
Do JY; Kim YL; Park JW; Chang KA; Lee SH; Ryu DH; Kim CD; Park SH; Yoon KW
Perit Dial Int; 2008 Jun; 28 Suppl 3():S101-6. PubMed ID: 18552237
[TBL] [Abstract][Full Text] [Related]
13. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane.
Williams JD; Topley N; Craig KJ; Mackenzie RK; Pischetsrieder M; Lage C; Passlick-Deetjen J;
Kidney Int; 2004 Jul; 66(1):408-18. PubMed ID: 15200450
[TBL] [Abstract][Full Text] [Related]
14. Effects of Conversion to a Bicarbonate/Lactate-Buffered, Neutral-pH, Low-GDP PD Regimen in Prevalent PD: A 2-Year Randomized Clinical Trial.
Farhat K; Douma CE; Ferrantelli E; Ter Wee PM; Beelen RHJ; van Ittersum FJ
Perit Dial Int; 2017; 37(3):273-282. PubMed ID: 28348100
[TBL] [Abstract][Full Text] [Related]
15. Biocompatibility of a bicarbonate/lactate-buffered PD fluid tested with a double-chamber cell culture system.
Fusshoeller A; Baehr J; Grabensee B; Plum J
Perit Dial Int; 2005; 25(4):387-93. PubMed ID: 16022097
[TBL] [Abstract][Full Text] [Related]
16. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up.
Zweers MM; Struijk DG; Smit W; Krediet RT
J Lab Clin Med; 2001 Feb; 137(2):125-32. PubMed ID: 11174469
[TBL] [Abstract][Full Text] [Related]
18. Growth factors VEGF and TGF-beta1 in peritoneal dialysis.
Zweers MM; de Waart DR; Smit W; Struijk DG; Krediet RT
J Lab Clin Med; 1999 Aug; 134(2):124-32. PubMed ID: 10444025
[TBL] [Abstract][Full Text] [Related]
19. Biocompatibility and tolerability of a purely bicarbonate-buffered peritoneal dialysis solution.
Weiss L; Stegmayr B; Malmsten G; Tejde M; Hadimeri H; Siegert CE; Ahlmén J; Larsson R; Ingman B; Simonsen O; van Hamersvelt HW; Johansson AC; Hylander B; Mayr M; Nilsson PH; Andersson PO; De los Ríos T
Perit Dial Int; 2009; 29(6):647-55. PubMed ID: 19910566
[TBL] [Abstract][Full Text] [Related]
20. Comparison between bicarbonate/lactate and standard lactate dialysis solution in peritoneal transport and ultrafiltration: a prospective, crossover single-dwell study.
Fang W; Mullan R; Shah H; Mujais S; Bargman JM; Oreopoulos DG
Perit Dial Int; 2008; 28(1):35-43. PubMed ID: 18178946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]